Eosinophilic pneumonia in an asthmatic patient treated with omalizumab therapy: forme-fruste of Churg-Strauss syndrome?
Cazzola
M
M
Department of Internal Medicine, University of Rome 'Tor Vergata', Rome, Italy. mario.cazzola@uniroma2.it
Mura
M
M
Segreti
A
A
Mattei
M A
MA
Rogliani
P
P
D000328:Adult; D000485:Allergens / Q000276:immunology; D018927:Anti-Asthmatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D015267:Churg-Strauss Syndrome / Q000000981:diagnostic imaging / Q000209:etiology*; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D008168:Lung / Q000000981:diagnostic imaging / Q000473:pathology; D008297:Male; D000069444:Omalizumab; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D011657:Pulmonary Eosinophilia / Q000000981:diagnostic imaging / Q000209:etiology*; D011859:Radiography
D000485:Allergens; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E; D011241:Prednisone